Q-linea AB (publ) (OMX: QLINEA) today announces that Jim Kathrein will step down as VP US Commercial Operations. Ethan Suttles, who has served as US Director of Strategic Accounts since December 2023, will lead the US sales team and report directly to CEO Stuart Gander as of February 1, 2026.
Jim will support a smooth transition of responsibilities for US activities during Q1 2026. Natalie Brown, Director Global Marketing and Vikas Gupta, Senior Director of Clinical Affairs already hold global roles based in the US and will report directly to Stuart Gander.
CEO, Stuart Gander, comments, “I would like to thank Jim for his successful efforts in establishing a strong US team and building our commercial capabilities in the largest diagnostic market. Our US leadership team with Ethan, Natalie and Vikas representing Sales, Marketing and Clinical Affairs respectively are focused on executing our commercial strategy and converting our growing pipeline of ASTar to clinical use going into 2026.”